Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

9amHealth vs Hims & Hers

9amHealth
Graded #93

Lower grade

vs+9.700000000000003
Hims & Hers
Graded #36

Higher grade

The verdict

Hims & Hers takes it — 81/100 to 71.3/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHims & Hers +14
68
82
Dose & formulationHims & Hers +13
65
78
Clinical oversight9amHealth +6
88
82
Labs & monitoringHims & Hers +6
74
80
FulfillmentHims & Hers +16
68
84
Contract termsHims & Hers +25
55
80
9amHealth · left barHims & Hers · right bar

The numbers

Metric9amHealthHims & Hers
WeighScore71.3/10081/100
GradeCB−
Scorecard rank#93#36
Semaglutide$149/mo (plus a separate fee, brand-name)$199/mo
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
9amHealth

Graded #93 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
  • $149/month membership or free when covered by insurance
  • Membership includes specialists, labs, devices, and medications
  • Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
  • Helps navigate insurance approvals; employer and state-plan partnerships

Where it loses points

  • Medication coverage and GLP-1 access depend on insurance and BMI criteria
  • State availability not enumerated on the public site
  • Branded GLP-1s can be costly without insurance coverage
  • Pricing for medications not transparently listed
Hims & Hers

Graded #36 · B−

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard